Print Page

Pandemic H1N1 Flu Virus Fate

Author: NIH/National Institute of Allergy and Infectious Diseases
Published: 2010/09/28
Topic: H1N1 Virus (Swine Flu) (Publications Database)

Page Content: Synopsis Introduction Main Item

Synopsis: Possible future courses for the 2009 pandemic H1N1 (pH1N1) virus during the upcoming flu season.

Introduction

NIH scientists consider fate of pandemic H1N1 flu virus - Whither pandemic H1N1 virus

Main Item

In a new commentary, scientists from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, review the fates of previous pandemic influenza viruses in the years following a pandemic and speculate on possible future courses for the 2009 pandemic H1N1 (pH1N1) virus during the upcoming flu season and beyond.

The authors estimate that at least 183 million Americans (about 59 percent of the total U.S. population) have some immunity to pH1N1 because they were exposed to related viruses or vaccines prior to 2009, were immunized against pH1N1 or developed immunity following infection with the pandemic virus.

To stay in circulation in the face of such high levels of population immunity, the pH1N1 virus must adapt either through abrupt or gradual changes. The authors briefly examine a number of earlier pandemics and trace paths taken by the causative viruses. Some for reasons not well understood died out, while others, like those of 1889 and 1918, returned in an explosive fashion. Such an explosive return of pH1N1 virus is unlikely, note the authors, because global levels of immunity are already high and will increase further through immunization with 2010-2011 seasonal influenza vaccines, which contain the pH1N1 strain.

In light of what is known about pH1N1, the NIAID authors express a cautious optimism that unless it disappears entirely the virus will follow a route like that of 1968 pandemic virus, that is, it will persist in a form that causes relatively few deaths.

Nevertheless, the authors caution against complacency. As they acknowledge, many gaps remain in understanding how a given pandemic influenza virus adapts to increased immunity in humans. For that reason, influenza vaccination for everyone older than six months is a wise public health measure to maintain high levels of population-wide immunity. Immunization with 2010-2011 seasonal flu vaccine is particularly urged for babies older than six months, children, teens and young adults as the best way to protect individuals in those potentially more susceptible age groups from illness.

Additional information about NIAID's research programs in influenza is available at www.niaid.nih.gov/topics/flu/Pages/default.aspx.

DM Morens et al. The 2009 H1N1 pandemic influenza virus: What next? mBio DOI: 10.1128/mBio.00211-10 (2010).

Anthony S. Fauci, M.D., Director, NIAID; David M. Morens, M.D., Senior Scientific Adviser, NIAID; Jeffery K. Taubenberger, M.D., Ph.D., Senior Investigator, Laboratory of Infectious Diseases, NIAID, are available to provide comment.

To schedule interviews, please contact the NIAID Office of Communications, 301-402-1663, niaidnews@niaid.nih.gov

NIAID conducts and supports research at NIH, throughout the United States, and worldwide to study the causes of infectious and immune-mediated diseases, and to develop better means of preventing, diagnosing and treating these illnesses. News releases, fact sheets and other NIAID-related materials are available on the NIAID Web site at www.niaid.nih.gov.

The National Institutes of Health (NIH) The Nation's Medical Research Agency includes 27 Institutes and Centers and is a component of the U. S. Department of Health and Human Services. It is the primary federal agency for conducting and supporting basic, clinical and translational medical research, and it investigates the causes, treatments and cures for both common and rare diseases. For more information about NIH and its programs, visit www.nih.gov

Explore Similar Topics

1 - - Research led by The Hong Kong Polytechnic University discovers immunity from H1N1 with vaccine shot only lasts for two years.

2 - - Outbreak of 2013-2014 H1N1 flu virus reported in a number of Canadian Provinces and U.S. states, health officials recommend flu shots.

3 - - Study reveals simultaneous infection with methicillin-resistant Staphylococcus aureus (MRSA) increased risk for H1N1 flu-related mortality among previously healthy children.

Complete Publications Database


Page Information, Citing and Disclaimer

Disabled World is a comprehensive online resource that provides information and news related to disabilities, assistive technologies, and accessibility issues. Founded in 2004 our website covers a wide range of topics, including disability rights, healthcare, education, employment, and independent living, with the goal of supporting the disability community and their families.

Cite This Page (APA): NIH/National Institute of Allergy and Infectious Diseases. (2010, September 28). Pandemic H1N1 Flu Virus Fate. Disabled World. Retrieved December 7, 2024 from www.disabled-world.com/health/influenza/swine-flu/virus-fate.php

Permalink: <a href="https://www.disabled-world.com/health/influenza/swine-flu/virus-fate.php">Pandemic H1N1 Flu Virus Fate</a>: Possible future courses for the 2009 pandemic H1N1 (pH1N1) virus during the upcoming flu season.

While we strive to provide accurate and up-to-date information, it's important to note that our content is for general informational purposes only. We always recommend consulting qualified healthcare professionals for personalized medical advice. Any 3rd party offering or advertising does not constitute an endorsement.